Abstracts

Incidence of Curable Sexually Transmitted Infections Among South African Women Recently Infected With HIV

Background: Curable sexually transmitted infections (STIs), including chlamydia (CT), gonorrhea (GC), and trichomoniasis (TV) are common among HIV-infected women; however, data are limited for women recently infected with HIV. We assessed the incidence of and risk factors for CT, GC and TV among South African women who acquired HIV while participating in VOICE, a phase…

HIV Transmission Linkage Among Seroconverting Partners in HIV-Discordant Relationships in Kenya

Background: A large proportion of HIV-1 transmissions occur in the context of stable, HIV-discordant relationships. Understanding the distribution of infections that originate from within the current partnership (linked) versus from an outside sexual relation (unlinked) is relevant to prevention interventions. We obtained viral sequences from newly HIV-1 infected individuals and their HIV-infected partners at seroconversion…

Rising School Enrollment & Declining HIV Risk, 15-19y, Rakai, Uganda, 1994-2013

Background: Economic development, family stability, and social policies influence the ability of adolescents to attend school. Likewise, rising school enrollment may shape social developmental transitions and risk for HIV among youth. Methods: We examined longitudinal quantitative data from the Rakai Community Cohort Study (RCCS) for adolescents (n=11,829 person-rounds for women and 9906 person-rounds for men)…

Reversibility of Kidney Function Decline in HIV-1–Uninfected Men and Women Using Preexposure Prophylaxis

Background: Tenofovir disoproxil fumarate pre-exposure prophylaxis (PrEP) use is associated with a small but statistically significant decline in estimated glomerular filtration rate (eGFR). We investigated the occurrence and reversibility of eGFR decline among HIV-1 uninfected adults discontinuing PrEP. Methods: Data are from the Partners PrEP Study, a trial of daily oral tenofovir disoproxil fumarate (TDF)…

Minor Drug-Resistant Variants Infrequently Detected in Seroconverters From MTN 003 (VOICE)

Background: Minor (low frequency) drug-resistant variants selected by antiretroviral (ARV)-based prevention could negatively impact response to future antiretroviral therapy. We previously reported (Marrazzo et al., NEJM 2014) that acquired resistance to ARV-based products in the MTN 003 (VOICE) study was rarely detected by standard population based genotype analysis (1/212 participants receiving active product), with no…

PrEP-Selected Drug Resistance Fades by Six Months Following Drug Cessation

Background: Pre-exposure prophylaxis (PrEP) significantly reduces HIV-1 transmission. However, selection for drug resistance may occur when PrEP is initiated during unrecognized acute infection or in breakthrough infections during periods of low PrEP adherence. In these cases it remains unclear how long resistance persists after discontinuation of PrEP. Methods: The Partners PrEP Study was a randomized…

Randomized Controlled Trial on ART Outcomes in Tenofovir Gel Trial Seroconvertors

Background: Prior to promoting tenofovir gel for HIV prevention in women, it is important to know whether tenofovir gel users who acquire HIV infection can be treated with tenofovir containing antiretroviral treatment (ART) with good clinical outcomes. The CAPRISA009 randomised clinical trial assessed ART outcomes in women who acquired HIV during tenofovir gel trials. Methods:…

Frequent Dapivirine Cross-Resistance of HIV from 1st-line ART Failures in S. Africa

Background: Two Phase III studies (IPM Ring Study and MTN ASPIRE) are currently evaluating whether monthly use of a vaginal ring containing dapivirine (DPV) prevents HIV infection in women. The rise of transmitted EFV- and NVP-resistant virus could reduce the protective efficacy of DPV. This study investigated DPV cross-resistance among recombinant subtype C viruses derived…